(2022) found that SNHG15 was significantly highly expressed in monocytes in PBMCs of stroke patients, and IL-4 promoted the expression of SNHG15, LPS inhibited the expression of SNHG15, and SNHG15 could partially inhibit the transformation of macrophages to M1 type. Here, SNHG15 is linked to stroke disorder.